Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload;Efeitos da inibição prolongada da enzima de conversão da angiotensina sobre as caracteristícas morfológicas e funcionais da hipertrofia ventricular esquerda em ratos com sobrecarga pressórica persistente

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 3, 2005, Pages 225-232

  Bregagnollo, Edson Antonio ^a,b,c   Okoshi, Katashi ^a,b   Bregagnollo, Isamara Fernanda ^a,b   Padovani, Carlos Roberto ^a,b   Okoshi, Marina P ^a,b   Cicogna, Antonio Carlos ^a,b  

^a UNESP ^*

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Faculdad de Medicina   (Brazil)

Author keywords

Angiotensin converting enzyme inhibitors; Arterial hypertension; Cardiac hypertrophy; Lisinopril; Ventricular function

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYPROLINE; LISINOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SUPRAVALVULAR STENOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; MORTALITY; NONHUMAN; RAT;

EID: 17644407665     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2005000300006     Document Type: Article

References (50)

1. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991; 83:13-25.
2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe heart failure: results of the Cooperative North Scandinavan Enalapril Study Group. N Engl J Med 1987; 316:1429-35.
3. The SOLVD Investigators. Effects of enalapril on mortality and the developmente of heart failure in asymtomatic patients with reduced left ventricular ejections fractions. N Engl J Med 1992; 327:685-91.
4. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P, Survival after an experimental myocardial infarctation: beneficial effects of long-term therapy with captopril. Circulation 1985; 72:406-12.
5. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 1992; 20:147-56.
6. Hallen SJ, Weishaar RE, Overhiser RW, et al. Effects of quinalapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster, morphological and biochemical correlattes. Circ Res 1991; 68:1302-12.
7. Dahlof B, Pennert K, Hansson H. Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens 1992; A14:173-80.
8. Routledge HC, Townend J. N. ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity? J Hum Hypertension 2001; 15:659-67.
9. Kromer EP, Elsner D, Riegger GAJ. Roleof neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens 1991; 4:521-4.
10. Dzau VJ. Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol 1992; 70:4C-11C.
11. Kenneth MB, Booz GW, Dortal DE. Cardiac actions of angiotensin II; Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992; 54:227-41.
12. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990; 259:H324-H32.
13. Levy D. Clinical significance of the left ventricular hypertrophy: insights from the Framingham Study. J Cardiovasc Pharmacol 1991; 17(suppl. 2):S1-S6.
14. Feldman A, Weinberg ED, Ray P, Lorell BH. Selective changes in gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993; 73:184-92.
15. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein GS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistances, contractility and relaxation. J Clin Invest 1990; 1913-20.
16. Schunkert H, Jackson B, Tang SS, et al. Distribution and functional significance of cardiac ACE in hypertrophied rat hearts. Circulation 1993; 87; 1328-39.
17. Kabour A, Henegar JR, Devineri VR, Janicki JS. Prevention of angiotensin II induced myocite necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovascular Res 1995; 29:543-8.
18. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular function after larger myocardial infarction in the rat. Circulation 1994; 89:345-54.
19. Okoshi K. Estrutura e função do coração de ratos normotensos e hipertensos submetidosa restrição da ingestão alimentar: estudo in vivo pelo ecocardiograma e in vitro do coração isolado. Tese de Doutoramento. Faculdade de Medicina de Botucatu - UNESP, 2000.
20. Switzer, BR. Determination of hidroxiproline in tissue. J. Nutr. Biochem 1991; 2:229-231.
21. Hassenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 1998; 39:60-76.
22. Grossman W, Carabello BA, Gunther S, Fifer MA. Ventricular wall stress and development of cardiac hypertrophy and failure. In: Alpert, NR ed. Perspectives in Cardiovascular Research. New York, NY: Raven Press; 1983:1-18.
23. Weber KT, Pick R, Jalil JE, Janick JS, Carrol EP. Patterns of myocardial fibrosis. J Mol Cell Cardiol 1989; 21 (suppl. V):121-31.
24. Weinberg EO, Schoen FJ, Dorinda BA, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994; 90:1410-22.
25. Isoyama S, Ito N, Koroha M, Takashima T. Complete reversibility of physiologic coronary flow abnormalities in hypertrophied hearts produced by pressure-overload in the rat. J Clin Invest 1989; 84:288-94.
26. Eberli FR, Apstein GS, Ngoy S, Lorell BH. Exacerbation of left ventricular ischemia diastolic dysfunction by pressure overload hypertrophy: modification by specific inibition of cardiac angiotensin converting enzyme. Circ Res 1992; 70:931-43.
27. Linz W, Schoelkens B, Hany F. Beneficals effects of the converting enzyme inhibitor, ramipril in ischemic rat hearts. J Cardiovasc Pharmacol 1986; 8 (suppl. 10):S91-S9.
28. Fleetwood G, Boutinet S, Meier M, Woody M. Involvement of the renin-angiotensin systens in ischemic damage and reperfusion arrhytmias in the isolated perfused rat heart. J Cardiovasc Pharmacol 1991; 17:351-6.
29. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43:838-49.
30. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83:1849-65.
31. Mukherjer D, Sen S. Collagen phenotype during development and regression of myocardial hypertrophy in spontaneously hypertension rats. Circ Res 1990; 67:1474-80.
32. Koide M, Carabello BA, Conrad CC, et GL. Hypertrophic response to hemodynamic system activation. Am J Physiol 1999; 276 (Heart Circ Physiol 45):H350-H8.
33. Rockman HA, Wachhorst SP, Moo L, Ross JrJ. Ang II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload mice. Am J Physiol 1994; 2661 (Heart Circ Physiol 35):H2468-75.
34. Weinberg EO, Lee MA, Weigner M, et GL. Angiotensin AT-1 receptor inhibition. Circulation 1997; 95:1592-600.
35. Zierhut W, Zimmer HG, Gerdes AM. Influence of ramipril on right ventricular hypertrophy induced by pulmonary artery stenosis in rats. J Cardiovasc Pharmacol 1990; 16:480-6.
36. Zierhut W, Zimmer HG, Gerdes AM. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 1991; 69:609-17.
37. Kingsbury M, Mahnke A, Turner M, Sheridan D. Recovery of coronary function and morphology during regression of left ventricular hypertrophy. Cardiovasc Res 2002; 55:83-96.
38. Balke CW, Shorofsky: Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998; 37:290-9.
39. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Douglas PS. Chronic ACE inhibition attenuates progression of systolic and diastolic dysfunction. Circulation 1993; 88(suppl. I):1-527.
40. Tombe PP. Altered contractile function in heart failure. Cardiovasc Res 1998; 37:367-80.
41. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Ver 1999; 79:215-62.
42. Maisch B. Ventricular remodeling. Cardiology 1996; 87(suppl 1):2-10.
43. Willenheimer R. Left ventricular remodeling and dysfunction can the process be prevented? Intern J Cardiol 2000; 72:143-50.
44. Spinale FG, Mukherjee R, Iannini JP et GL. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure II. Effects on myocyte contractile processes. Circulation 1997; 96:2397-403.
45. Spinale FC, de Gasparo M, Whitebread S et GL. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I. Effects on left ventricular performance and neurohumoral systems. Circulation 1997; 96:2385-96.
46. Litwin SE, Morgan P. Captopril enhances intracellular calcium handling and â-adrenergic responsiveness of myocardium from rats with post-infarction failure. Circ Res 1992; 71:797-807.
47. +2 in myocytes from aortic-banded rats. Circulation 1996; 94:2915-22.
48. Dostal DE, Baker KM. The cardiac renin-angiotensin system. Conceptual, or a regulator of cardiac function? Circ Res 1999; 85:643-50.
49. Neyes L, Vetter H. Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II. J Hypertens 1989; 7(suppl.):S104-S105.
50. Friedrich SP, Lorell BH, Douglas PS, et al. Intracardiac ACE inhibition improves diastolic distensibility in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994; 90:2761-71.